In this regard, calcineurin directly regulates ERα stability and activity in breast cancer and estrogen upregulates calcineurin expression via overexpression of ER in systemic lupus erythematosus (Rider et al., 2000; Lin et al., 2011; Masaki et al., 2021). Here, ESR1 is linked to breast carcinoma.